EVOKE PHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
EVOKE PHARMA, INC. had Lessee, Operating Lease, Liability, to be Paid, Year One of $80.21 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2025-11-13
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $80.21K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $80.21K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $80.21K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $77.87K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2025-09-30 | $80.21K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $80.21K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $80.21K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $77.87K 10-K · filed 2025-03-13 | |
| 2023-12-31 | $63.00K 10-K/A · filed 2024-05-14 | |
| 2023-09-30 | $13.37K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $53.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $94.00K 10-Q · filed 2023-05-15 | |
| 2022-09-30 | $39.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $50.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $87.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $134.00K 10-K · filed 2023-03-21 | $12.00K 10-K · filed 2022-03-08 |